Menu
Nifty
Sensex
:
:
22547.55
74602.12
-5.80 (-0.03%)
147.71 (0.20%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 544067 | NSE: INNOVACAP

950.55
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  978.00
  •  983.90
  •  924.00
  •  1007.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  177604
  •  1683.52
  •  1260.00
  •  421.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,437.79
  • 34.83
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,678.32
  • N/A
  • 4.77

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.90%
  • 0.96%
  • 26.96%
  • FII
  • DII
  • Others
  • 0.74%
  • 12.70%
  • 7.74%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 10.54

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 9.97

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 13.84

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
11.91
P/E Ratio
85.58
Revenue
865
1391
1917
2267
EBITDA
154
211
293
358
Net Income
94
143
199
249
ROA
7.4
P/Bk Ratio
7.02
5.97
4.98
4.13
ROE
14.69
13.31
14.96
19.9
FCFF
245.65
-1791.2
1084.4
902.5
FCFF Yield
3.99
-29.11
17.63
14.67

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
316.46
302.49
4.62%
318.20
282.94
12.46%
294.27
233.24
26.17%
262.63
240.94
9.00%
Expenses
269.90
257.89
4.66%
268.47
242.47
10.72%
252.09
201.94
24.83%
224.56
214.15
4.86%
EBITDA
46.56
44.60
4.39%
49.73
40.48
22.85%
42.18
31.30
34.76%
38.08
26.80
42.09%
EBIDTM
14.71%
14.74%
15.63%
14.31%
14.33%
13.42%
14.50%
11.12%
Other Income
4.33
2.34
85.04%
2.22
3.34
-33.53%
2.12
1.13
87.61%
5.69
2.62
117.18%
Interest
0.17
6.80
-97.50%
0.15
8.81
-98.30%
0.14
5.03
-97.22%
0.81
5.23
-84.51%
Depreciation
5.13
4.93
4.06%
4.99
4.83
3.31%
4.85
2.79
73.84%
3.41
2.94
15.99%
PBT
45.59
35.20
29.52%
46.81
30.18
55.10%
39.31
24.60
59.80%
39.55
21.25
86.12%
Tax
11.38
10.07
13.01%
11.80
7.28
62.09%
9.83
7.01
40.23%
10.82
3.99
171.18%
PAT
34.20
25.13
36.09%
35.00
22.91
52.77%
29.48
17.59
67.60%
28.72
17.25
66.49%
PATM
10.81%
8.31%
11.00%
8.10%
10.02%
7.54%
10.94%
7.16%
EPS
5.98
4.39
36.22%
6.12
4.77
28.30%
5.15
3.67
40.33%
5.02
3.59
39.83%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 21
Net Sales
913.64
864.93
858.67
410.66
Net Sales Growth
3.43%
0.73%
109.10%
 
Cost Of Goods Sold
675.97
505.56
528.35
273.02
Gross Profit
237.67
359.37
330.33
137.65
GP Margin
26.01%
41.55%
38.47%
33.52%
Total Expenditure
796.13
756.96
760.14
356.18
Power & Fuel Cost
-
11.58
9.42
5.48
% Of Sales
-
1.34%
1.10%
1.33%
Employee Cost
-
50.11
43.60
22.33
% Of Sales
-
5.79%
5.08%
5.44%
Manufacturing Exp.
-
156.32
152.17
43.28
% Of Sales
-
18.07%
17.72%
10.54%
General & Admin Exp.
-
19.96
17.37
8.59
% Of Sales
-
2.31%
2.02%
2.09%
Selling & Distn. Exp.
-
4.81
4.38
2.18
% Of Sales
-
0.56%
0.51%
0.53%
Miscellaneous Exp.
-
8.62
4.87
1.30
% Of Sales
-
1.00%
0.57%
0.32%
EBITDA
117.51
107.97
98.53
54.48
EBITDA Margin
12.86%
12.48%
11.47%
13.27%
Other Income
18.42
10.72
8.73
1.37
Interest
0.42
13.59
18.30
3.93
Depreciation
12.14
11.40
10.66
5.59
PBT
123.39
93.70
78.31
46.34
Tax
31.32
25.54
20.75
11.84
Tax Rate
25.38%
27.26%
26.50%
25.55%
PAT
92.07
68.16
57.55
34.50
PAT before Minority Interest
92.07
68.16
57.55
34.50
Minority Interest
0.00
0.00
0.00
0.00
PAT Margin
10.08%
7.88%
6.70%
8.40%
PAT Growth
48.64%
18.44%
66.81%
 
EPS
16.10
11.92
10.06
6.03

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 21
Shareholder's Funds
723.72
268.32
144.82
Share Capital
57.23
48.00
12.00
Total Reserves
666.49
220.32
132.82
Non-Current Liabilities
217.95
191.49
9.64
Secured Loans
208.20
62.34
6.00
Unsecured Loans
0.00
71.83
0.00
Long Term Provisions
2.67
43.55
1.23
Current Liabilities
237.97
259.32
215.15
Trade Payables
153.51
148.08
112.23
Other Current Liabilities
35.62
12.80
68.96
Short Term Borrowings
22.82
97.93
33.43
Short Term Provisions
26.03
0.50
0.53
Total Liabilities
1,179.64
719.13
369.61
Net Block
163.56
161.37
79.14
Gross Block
207.13
194.75
95.61
Accumulated Depreciation
43.57
33.38
16.47
Non Current Assets
717.63
340.75
99.15
Capital Work in Progress
338.98
21.54
7.26
Non Current Investment
60.00
60.00
0.00
Long Term Loans & Adv.
154.90
97.58
12.75
Other Non Current Assets
0.20
0.26
0.00
Current Assets
462.01
378.38
270.46
Current Investments
0.00
0.00
0.00
Inventories
93.99
97.27
91.44
Sundry Debtors
217.39
229.68
138.55
Cash & Bank
86.35
14.98
11.89
Other Current Assets
64.28
10.86
2.52
Short Term Loans & Adv.
60.72
25.58
26.05
Net Current Assets
224.04
119.06
55.31
Total Assets
1,179.64
719.13
369.61

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 21
Cash From Operating Activity
111.67
39.28
41.56
PBT
93.70
78.31
46.34
Adjustment
22.31
23.58
9.59
Changes in Working Capital
19.65
-43.70
-1.14
Cash after chg. in Working capital
135.66
58.19
54.80
Interest Paid
0.00
0.00
0.00
Tax Paid
-23.99
-18.91
-13.23
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-471.55
-87.53
-19.67
Net Fixed Assets
-329.82
-113.42
Net Investments
0.00
-60.00
Others
-141.73
85.89
Cash from Financing Activity
368.13
51.29
-19.34
Net Cash Inflow / Outflow
8.25
3.03
2.56
Opening Cash & Equivalents
3.13
0.10
2.23
Closing Cash & Equivalent
11.39
3.13
4.80

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 21
Book Value (Rs.)
126.47
55.90
30.17
ROA
7.18%
9.02%
11.06%
ROE
13.74%
24.02%
27.04%
ROCE
14.62%
21.70%
28.42%
Fixed Asset Turnover
4.31
4.53
4.59
Receivable days
94.22
85.66
100.13
Inventory Days
40.31
43.00
69.74
Payable days
108.87
99.66
122.96
Cash Conversion Cycle
25.66
29.00
46.92
Total Debt/Equity
0.33
0.88
0.31
Interest Cover
7.89
5.28
12.80

Annual Reports:

News Update:


  • Innova Captab - Quarterly Results
    5th Feb 2025, 17:11 PM

    Read More
  • Innova Captab commences commercial production at Jammu facility
    15th Jan 2025, 09:58 AM

    With this expansion, the company, at a consolidated level, has total five manufacturing facilities with nine independent manufacturing blocks

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.